1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Veverka, V. Bauerova, H. Zabransky, A. Lang, J. Ruml, T. Pichova, I. Hrabal, R. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.MOL.BIOL. JMOBAK 0070 0022-2836 333 771 780 10.1016/j.jmb.2003.08.049 14568536 Three-dimensional structure of a monomeric form of a retroviral protease 2003 10.2210/pdb1nso/pdb pdb_00001nso 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 12189.059 Protease 13 kDa 3.4.23.- C7A, C106A, D26N 1 man polymer no no WVQPITAQKPSLTLWLDDKMFTGLINTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI KPFVIPNLPVNLWGRDLLSQMKIMMAS WVQPITAQKPSLTLWLDDKMFTGLINTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI KPFVIPNLPVNLWGRDLLSQMKIMMAS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Betaretrovirus Mason-Pfizer monkey virus Escherichia sample 1 107 pol 11942 Simian retrovirus SRV-1 562 Escherichia coli PLASMID Biological sequence database_2 pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif entity entity_src_gen struct_ref struct_ref_seq struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Database references Source and taxonomy Structure summary 1 0 2003-02-18 1 1 2008-04-29 1 2 2011-07-13 1 3 2021-10-27 1 4 2021-11-10 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details _entity.pdbx_description _entity_src_gen.pdbx_beg_seq_num _entity_src_gen.pdbx_end_seq_num _entity_src_gen.pdbx_gene_src_gene _entity_src_gen.pdbx_gene_src_scientific_name _entity_src_gen.pdbx_seq_type _struct_ref.db_code _struct_ref.pdbx_align_begin _struct_ref.pdbx_db_accession _struct_ref_seq.db_align_beg _struct_ref_seq.db_align_end _struct_ref_seq.pdbx_db_accession _struct_ref_seq_dif.pdbx_seq_db_accession_code _struct_ref_seq_dif.pdbx_seq_db_seq_num RCSB Y RCSB 2003-01-28 REL REL The structure was determined using triple-resonance NMR spectroscopy. structures with the least restraint violations 100 10 3D_13C-separated_NOESY 3D_15N-separated_NOESY 4D_13C/15N-separated_NOESY 50 mM 4.2 ambient 298 K torsion angle dynamics 4 lowest energy 1mM Protease U-15N,13C; 50mM acetate buffer NA 95% H2O/5% D2O Bruker collection XwinNMR 3.1 Delaglio, F. processing NMRPipe 2.1 Goddard, T.D., Kneller, D.G. data analysis Sparky 3.106 Linge, J., O'Donoghue, S., Nilges, M. structure solution ARIA 1.1 Linge, J., O'Donoghue, S., Nilges, M. refinement ARIA 1.1 500 Bruker AVANCE TRP 1 n 1 TRP 1 A VAL 2 n 2 VAL 2 A GLN 3 n 3 GLN 3 A PRO 4 n 4 PRO 4 A ILE 5 n 5 ILE 5 A THR 6 n 6 THR 6 A ALA 7 n 7 ALA 7 A GLN 8 n 8 GLN 8 A LYS 9 n 9 LYS 9 A PRO 10 n 10 PRO 10 A SER 11 n 11 SER 11 A LEU 12 n 12 LEU 12 A THR 13 n 13 THR 13 A LEU 14 n 14 LEU 14 A TRP 15 n 15 TRP 15 A LEU 16 n 16 LEU 16 A ASP 17 n 17 ASP 17 A ASP 18 n 18 ASP 18 A LYS 19 n 19 LYS 19 A MET 20 n 20 MET 20 A PHE 21 n 21 PHE 21 A THR 22 n 22 THR 22 A GLY 23 n 23 GLY 23 A LEU 24 n 24 LEU 24 A ILE 25 n 25 ILE 25 A ASN 26 n 26 ASN 26 A THR 27 n 27 THR 27 A GLY 28 n 28 GLY 28 A ALA 29 n 29 ALA 29 A ASP 30 n 30 ASP 30 A VAL 31 n 31 VAL 31 A THR 32 n 32 THR 32 A ILE 33 n 33 ILE 33 A ILE 34 n 34 ILE 34 A LYS 35 n 35 LYS 35 A LEU 36 n 36 LEU 36 A GLU 37 n 37 GLU 37 A ASP 38 n 38 ASP 38 A TRP 39 n 39 TRP 39 A PRO 40 n 40 PRO 40 A PRO 41 n 41 PRO 41 A ASN 42 n 42 ASN 42 A TRP 43 n 43 TRP 43 A PRO 44 n 44 PRO 44 A ILE 45 n 45 ILE 45 A THR 46 n 46 THR 46 A ASP 47 n 47 ASP 47 A THR 48 n 48 THR 48 A LEU 49 n 49 LEU 49 A THR 50 n 50 THR 50 A ASN 51 n 51 ASN 51 A LEU 52 n 52 LEU 52 A ARG 53 n 53 ARG 53 A GLY 54 n 54 GLY 54 A ILE 55 n 55 ILE 55 A GLY 56 n 56 GLY 56 A GLN 57 n 57 GLN 57 A SER 58 n 58 SER 58 A ASN 59 n 59 ASN 59 A ASN 60 n 60 ASN 60 A PRO 61 n 61 PRO 61 A LYS 62 n 62 LYS 62 A GLN 63 n 63 GLN 63 A SER 64 n 64 SER 64 A SER 65 n 65 SER 65 A LYS 66 n 66 LYS 66 A TYR 67 n 67 TYR 67 A LEU 68 n 68 LEU 68 A THR 69 n 69 THR 69 A TRP 70 n 70 TRP 70 A ARG 71 n 71 ARG 71 A ASP 72 n 72 ASP 72 A LYS 73 n 73 LYS 73 A GLU 74 n 74 GLU 74 A ASN 75 n 75 ASN 75 A ASN 76 n 76 ASN 76 A SER 77 n 77 SER 77 A GLY 78 n 78 GLY 78 A LEU 79 n 79 LEU 79 A ILE 80 n 80 ILE 80 A LYS 81 n 81 LYS 81 A PRO 82 n 82 PRO 82 A PHE 83 n 83 PHE 83 A VAL 84 n 84 VAL 84 A ILE 85 n 85 ILE 85 A PRO 86 n 86 PRO 86 A ASN 87 n 87 ASN 87 A LEU 88 n 88 LEU 88 A PRO 89 n 89 PRO 89 A VAL 90 n 90 VAL 90 A ASN 91 n 91 ASN 91 A LEU 92 n 92 LEU 92 A TRP 93 n 93 TRP 93 A GLY 94 n 94 GLY 94 A ARG 95 n 95 ARG 95 A ASP 96 n 96 ASP 96 A LEU 97 n 97 LEU 97 A LEU 98 n 98 LEU 98 A SER 99 n 99 SER 99 A GLN 100 n 100 GLN 100 A MET 101 n 101 MET 101 A LYS 102 n 102 LYS 102 A ILE 103 n 103 ILE 103 A MET 104 n 104 MET 104 A MET 105 n 105 MET 105 A ALA 106 n 106 ALA 106 A SER 107 n 107 SER 107 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 19 A O LYS 19 A N LEU 16 A N LEU 16 A N TRP 15 A N TRP 15 A O ARG 71 A O ARG 71 A N TRP 70 A N TRP 70 A O GLY 78 A O GLY 78 A N LEU 49 A N LEU 49 A O ASN 60 A O ASN 60 1 A A O HA ASP LYS 47 62 1.37 1 A A O CA ASP LYS 47 62 2.02 1 A A O CB ASP LYS 47 62 2.18 3 A A O HA ASP LYS 47 62 0.95 3 A A O CA ASP LYS 47 62 1.87 5 A A O H ASP ASN 72 75 1.59 6 A A HG3 HA GLN ILE 63 85 1.11 6 A A OE1 O GLN VAL 63 84 2.15 7 A A O HA ASP LYS 47 62 1.09 7 A A O CA ASP LYS 47 62 2.03 8 A A O O LEU ASN 49 60 2.17 9 A A O H ARG ILE 53 55 1.45 9 A A O N ARG ILE 53 55 2.19 1 A ALA 7 61.38 153.76 1 A GLN 8 -66.90 90.31 1 A ASP 17 67.06 -66.78 1 A ASP 18 -173.52 34.96 1 A GLN 57 -43.32 93.12 1 A SER 64 -34.50 163.23 1 A LYS 66 -33.97 111.77 1 A LYS 73 -39.78 -27.30 1 A ASN 75 75.39 45.04 1 A ASN 76 174.64 140.68 1 A SER 77 -168.73 -47.11 1 A LEU 88 68.36 84.61 1 A PRO 89 -77.25 29.61 1 A ASN 91 40.61 90.33 1 A LYS 102 179.04 49.75 1 A MET 105 -65.40 72.97 2 A ALA 7 60.68 -171.19 2 A ASP 17 24.07 34.30 2 A ASP 18 167.97 -47.80 2 A ASP 30 -147.45 -36.70 2 A LYS 35 -46.61 162.94 2 A PRO 40 -53.50 107.85 2 A THR 46 -65.99 -179.78 2 A ASP 47 148.56 -58.73 2 A GLN 57 -42.81 93.44 2 A LYS 66 -18.79 119.77 2 A LYS 73 -36.69 -30.20 2 A ASN 76 177.88 144.32 2 A SER 77 177.53 -45.64 2 A PRO 86 -86.09 48.29 2 A ASN 87 -144.99 13.67 2 A LEU 88 66.17 78.53 2 A PRO 89 -69.20 9.18 2 A VAL 90 95.09 -8.01 2 A ASN 91 54.71 86.53 2 A LYS 102 -147.10 -29.79 2 A ILE 103 -76.36 -87.41 2 A MET 105 -62.29 81.61 3 A ALA 7 61.74 -178.53 3 A GLN 57 -41.41 94.20 3 A SER 64 -27.67 154.77 3 A LYS 66 -31.59 146.22 3 A LYS 73 -35.50 -33.31 3 A SER 77 -174.21 -68.06 3 A PRO 86 -83.75 43.41 3 A LEU 88 65.69 86.03 3 A PRO 89 -77.87 27.13 3 A MET 104 -63.81 -174.82 3 A MET 105 -67.80 72.73 4 A ALA 7 60.51 -162.08 4 A PRO 10 -68.41 60.29 4 A ASP 30 -156.28 12.56 4 A LYS 35 -49.80 163.24 4 A THR 46 -65.89 -179.83 4 A ASP 47 173.40 -48.97 4 A GLN 57 -47.37 95.91 4 A ASN 60 -68.23 -179.90 4 A LYS 66 -22.98 114.52 4 A LYS 73 -38.57 -29.13 4 A ASN 76 -175.45 145.34 4 A SER 77 179.98 -43.33 4 A PRO 86 -81.97 35.83 4 A LEU 88 66.56 81.40 4 A PRO 89 -77.97 22.23 4 A ASN 91 44.67 90.50 4 A LYS 102 -178.07 42.01 4 A MET 105 -65.67 76.99 5 A ALA 7 62.77 130.33 5 A GLN 8 -67.26 90.19 5 A ASP 17 63.85 -67.90 5 A ASP 18 -179.52 41.65 5 A LYS 19 -170.13 148.58 5 A THR 27 -54.99 -9.98 5 A LYS 35 -48.02 163.24 5 A GLN 57 -47.79 90.40 5 A SER 64 -27.02 164.19 5 A LYS 66 -22.40 121.63 5 A ASN 75 76.79 44.31 5 A ASN 76 173.89 150.36 5 A SER 77 -173.11 -61.83 5 A LEU 88 66.49 79.50 5 A PRO 89 -79.07 23.81 5 A ASN 91 44.97 81.09 5 A LYS 102 -169.77 39.29 5 A MET 104 -52.08 175.55 6 A ALA 7 62.68 -163.12 6 A PRO 10 -70.92 48.80 6 A ASP 18 78.10 41.17 6 A ASP 30 -131.92 -43.56 6 A PRO 40 -56.15 109.24 6 A GLN 57 -44.28 92.49 6 A PRO 61 -32.33 179.47 6 A LYS 66 -12.23 111.73 6 A ASN 75 70.14 44.52 6 A ASN 76 -176.05 144.35 6 A SER 77 176.94 -51.71 6 A PRO 86 -83.09 43.60 6 A LEU 88 68.18 81.25 6 A PRO 89 -78.27 21.73 6 A LYS 102 -177.66 34.96 6 A MET 105 -62.30 97.22 7 A PRO 4 -58.61 98.05 7 A ALA 7 64.52 -175.40 7 A PRO 10 -82.46 47.63 7 A ASP 30 -132.40 -46.57 7 A THR 32 -54.66 102.27 7 A THR 48 -69.51 93.56 7 A GLN 57 -46.34 95.93 7 A SER 64 -103.42 -161.50 7 A LYS 66 22.36 100.81 7 A LYS 73 -38.40 -29.75 7 A ASN 76 -176.60 136.40 7 A SER 77 -178.08 -47.72 7 A LEU 88 77.90 70.92 7 A PRO 89 -72.47 25.32 7 A LYS 102 -172.28 33.92 7 A ILE 103 -107.50 -66.14 8 A PRO 4 -52.91 90.13 8 A ALA 7 61.25 169.27 8 A GLN 8 -61.15 90.29 8 A PRO 10 -84.73 48.43 8 A ASP 17 64.01 -74.36 8 A ASP 18 -168.10 37.95 8 A ASP 30 -133.07 -44.98 8 A ASP 47 174.46 -32.54 8 A GLN 57 -56.19 104.44 8 A LYS 66 -15.74 107.77 8 A SER 77 -178.25 -75.21 8 A PRO 86 -81.59 36.52 8 A LEU 88 77.54 81.66 8 A VAL 90 83.03 -3.03 8 A ASN 91 58.45 77.47 8 A LYS 102 -161.69 51.76 8 A ILE 103 -133.15 -73.20 9 A ALA 7 64.27 127.85 9 A GLN 8 -53.20 99.54 9 A PRO 10 -68.83 57.29 9 A PHE 21 -179.02 143.23 9 A ASP 30 -155.10 11.68 9 A LYS 35 -46.64 163.08 9 A ASP 47 159.80 -63.75 9 A ILE 55 47.56 27.08 9 A LYS 66 -30.01 137.75 9 A LYS 73 -37.75 -27.63 9 A SER 77 174.76 -83.53 9 A PRO 86 -82.71 48.42 9 A LEU 88 62.07 77.66 9 A PRO 89 -74.38 22.86 9 A ASN 91 47.37 84.06 9 A LYS 102 -158.87 29.75 9 A ILE 103 -101.22 -68.34 9 A MET 105 -58.62 87.34 10 A ALA 7 64.50 173.24 10 A ASP 17 46.97 28.65 10 A ASP 18 74.45 47.98 10 A LYS 35 -45.59 162.11 10 A THR 46 -65.95 -179.67 10 A ASP 47 174.59 -16.37 10 A GLN 57 -46.78 100.93 10 A SER 64 -35.94 155.21 10 A LYS 66 -31.51 130.72 10 A LYS 73 -31.17 -33.99 10 A SER 77 170.65 -74.27 10 A ASN 87 -151.97 11.93 10 A LEU 88 61.45 80.87 10 A PRO 89 -76.38 21.18 10 A VAL 90 76.37 -1.68 10 A ASN 91 52.60 84.48 10 A LYS 102 178.75 45.40 10 A MET 105 -65.92 75.72 Folded monomer of protease from Mason-Pfizer monkey virus 1 N N A LYS 35 A LYS 35 HELX_P A TRP 39 A TRP 39 5 1 5 A GLY 94 A GLY 94 HELX_P A ILE 103 A ILE 103 1 2 10 HYDROLASE M-PMV, PROTEASE, VIRUS MATURATION, FOLDED MONOMER, HYDROLASE POL_SRV1 UNP 1 761 P04025 WVQPITCQKPSLTLWLDDKMFTGLIDTGADVTIIKLEDWPPNWPITDTLTNLRGIGQSNNPKQSSKYLTWRDKENNSGLI KPFVIPNLPVNLWGRDLLSQMKIMMCS 761 867 1NSO 1 107 P04025 A 1 1 107 1 CYS engineered mutation ALA 7 1NSO A P04025 UNP 767 7 1 ASP engineered mutation ASN 26 1NSO A P04025 UNP 786 26 1 CYS engineered mutation ALA 106 1NSO A P04025 UNP 866 106 4 2 anti-parallel anti-parallel anti-parallel anti-parallel A LYS 19 A LYS 19 A GLY 23 A GLY 23 A LEU 12 A LEU 12 A LEU 16 A LEU 16 A LEU 68 A LEU 68 A ASP 72 A ASP 72 A ASN 76 A ASN 76 A ILE 80 A ILE 80 A LEU 49 A LEU 49 A LEU 52 A LEU 52 A GLN 57 A GLN 57 A ASN 60 A ASN 60